Sunvax Mrna Therapeutics Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Sunvax Mrna Therapeutics Inc.
Quantité totale PI 10
Rang # Quantité totale PI 157 388
Note d'activité PI 2,1/5.0    15
Rang # Activité PI 56 665
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

5 1
0 0
4 0
0
 
Dernier brevet 2025 - Methods for cascade amplificatio...
Premier brevet 2023 - Ionizable lipid compounds and li...
Dernière marque 2023 - SUNVAX MRNA THERAPEUTICS
Première marque 2023 - SUNVAX MRNA THERAPEUTICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Methods for cascade amplifications of therapeutic payloads (catp) & compositions for cancer immun...
2024 Invention Synthetic self-amplifying mrna molecules with secretion antigen and immunomodulator. Lipid nanopa...
Invention Compositions and methods for delivering molecules. Compositions comprising mRNA, self-amplifying...
Invention Compositions and methods for delivering molecules. ex vivoex vivo by contacting immune cells with...
2023 P/S Lipids used in the manufacture of cosmetics, beverages, food products and food supplements for in...
Invention Ionizable lipid compounds and lipid nanoparticle compositions. Novel ionizable lipids, compositi...
Invention Ionizable lipid compounds and lipid nanoparticle compositions. Novel ionizable lipids, compositio...